Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4593)
All Articles published online
|
Oct 21, 2009 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yoshikawa S, Zen Y, Fujii T, Sato Y, Ohta T, Aoyagi Y, Nakanuma Y. Characterization of CD133+ parenchymal cells in the liver: Histology and culture. World J Gastroenterol 2009; 15(39): 4896-4906 [PMID: 19842219 DOI: 10.3748/wjg.15.4896] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i39/4896.htm |
| Number | Citing Articles |
| 1 |
T Wang, H S Hu, Y X Feng, J Shi, N Li, W X Guo, J Xue, D Xie, S R Liu, M C Wu, S Q Cheng. Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. British Journal of Cancer 2010; 102(11): 1618 doi: 10.1038/sj.bjc.6605689
|
| 2 |
Hiroko Ikeda, Kenichi Harada, Yasunori Sato, Motoko Sasaki, Norihide Yoneda, Seiko Kitamura, Yoshiko Sudo, Akishi Ooi, Yasuni Nakanuma. Clinicopathologic Significance of Combined Hepatocellular-Cholangiocarcinoma With Stem Cell Subtype Components With Reference to the Expression of Putative Stem Cell Markers. American Journal of Clinical Pathology 2013; 140(3): 329 doi: 10.1309/AJCP66AVBANVNTQJ
|
| 3 |
Maurizio Romano, Francesco De Francesco, Giuseppe Pirozzi, Enrico Gringeri, Riccardo Boetto, Marina Di Domenico, Barbara Zavan, Giuseppe A. Ferraro, Umberto Cillo. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma. Oncoscience 2015; 2(5): 443 doi: 10.18632/oncoscience.163
|
| 4 |
Yu-Chin Liu, Chau-Ting Yeh, Kwang-Huei Lin. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells 2020; 9(6): 1331 doi: 10.3390/cells9061331
|
| 5 |
Sepideh Alavi Moghaddam, Faezeh Faghihi, Nasim Hayati Roodbari. Differentiation potential of human CD133 and CD34 positive hematopoietic stem cells into motor neuron- like cells; an in vitro study. MEDICAL SCIENCES JOURNAL 2018; 28(2): 92 doi: 10.29252/iau.28.2.92
|
| 6 |
Florian Haag, Anjana Manikkam, Daniel Kraft, Caroline Bär, Vanessa Wilke, Aleksander J. Nowak, Jessica Bertrand, Jazan Omari, Maciej Pech, Severin Gylstorff, Borna Relja. Selective Internal Radiotherapy Changes the Immune Profiles of Extracellular Vesicles and Their Immune Origin in Patients with Inoperable Cholangiocarcinoma. Cells 2022; 11(15): 2309 doi: 10.3390/cells11152309
|
| 7 |
Junfang Ji, Xin Wei Wang. Clinical Implications of Cancer Stem Cell Biology in Hepatocellular Carcinoma. Seminars in Oncology 2012; 39(4): 461 doi: 10.1053/j.seminoncol.2012.05.011
|
| 8 |
Hsing-Ju Wu, Pei-Yi Chu. Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications. International Journal of Molecular Sciences 2019; 20(17): 4154 doi: 10.3390/ijms20174154
|
| 9 |
George S. Wilson, Zenan Hu, Wei Duan, Aiping Tian, Xin M. Wang, Duncan McLeod, Vincent Lam, Jacob George, Liang Qiao. Efficacy of Using Cancer Stem Cell Markers in Isolating and Characterizing Liver Cancer Stem Cells. Stem Cells and Development 2013; 22(19): 2655 doi: 10.1089/scd.2012.0703
|
| 10 |
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategies. Therapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816287
|
| 11 |
Guangqiu Li, Chao Liu, Jian Yuan, Xiaoqin Xiao, Na Tang, Junmei Hao, Hongwei Wang, Xiuwu Bian, Yongjian Deng, Yanqing Ding. CD133+ single cell-derived progenies of colorectal cancer cell line SW480 with different invasive and metastatic potential. Clinical & Experimental Metastasis 2010; 27(7): 517 doi: 10.1007/s10585-010-9341-0
|
| 12 |
Fei Jiang, Juan Mu, Xingxing Wang, Xianqing Ye, Lu Si, Shilong Ning, Zhong Li, Yuan Li, Lian-Yue Yang. The Repressive Effect of miR-148a on TGF beta-SMADs Signal Pathway Is Involved in the Glabridin-Induced Inhibition of the Cancer Stem Cells-Like Properties in Hepatocellular Carcinoma Cells. PLoS ONE 2014; 9(5): e96698 doi: 10.1371/journal.pone.0096698
|
| 13 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3 doi: 10.1007/978-3-319-26956-6_1
|
| 14 |
Gongcai Qiu, Donglai Ma, Fujun Li, Dongsheng Sun, Zhaolin Zeng. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma. International Journal of Oncology 2019; doi: 10.3892/ijo.2019.4798
|
| 15 |
Izuru Ohtsubo, Tetsuo Ajiki, Yuichi Hori, Sae Murakami, Kazuya Shimizu, Tomoo Itoh, Michio Shimizu, Takumi Fukumoto, Yonson Ku. Distinctive expression of CD133 between intraductal papillary neoplasms of the bile duct and bile duct adenocarcinomas. Hepatology Research 2012; 42(6): 574 doi: 10.1111/j.1872-034X.2011.00954.x
|
| 16 |
Li-Li Liu, Da Fu, Yushui Ma, Xi-Zhong Shen. The Power and the Promise of Liver Cancer Stem Cell Markers. Stem Cells and Development 2011; 20(12): 2023 doi: 10.1089/scd.2011.0012
|
| 17 |
Hee Ju, Yumi Shim, Parthasarathy Arumugam, Joon Myong Song. Crosstalk-eliminated quantitative determination of aflatoxin B1-induced hepatocellular cancer stem cells based on concurrent monitoring of CD133, CD44, and aldehyde dehydrogenase1. Toxicology Letters 2016; 243: 31 doi: 10.1016/j.toxlet.2015.12.006
|
| 18 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_1-1
|
| 19 |
Toshio Kokuryo, Yukihiro Yokoyama, Masato Nagino. Recent advances in cancer stem cell research for cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2012; 19(6): 606 doi: 10.1007/s00534-012-0542-6
|
| 20 |
Kuo-Shyang Jeng, Ssu-Jung Lu, Chih-Hsuan Wang, Chiung-Fang Chang. Liver Fibrosis and Inflammation under the Control of ERK2. International Journal of Molecular Sciences 2020; 21(11): 3796 doi: 10.3390/ijms21113796
|
| 21 |
L Florianova, M Orain, B Têtu, CJ Doillon. Histological study of stem-like cells in human colon adenocarcinoma at different stages of the disease. Biotechnic & Histochemistry 2013; 88(5): 222 doi: 10.3109/10520295.2012.758310
|
| 22 |
Lu Liu, Jürgen Borlak. Advances in Liver Cancer Stem Cell Isolation and their Characterization. Stem Cell Reviews and Reports 2021; 17(4): 1215 doi: 10.1007/s12015-020-10114-6
|
| 23 |
Giuseppa Zannini, Renato Franco, Federica Zito Marino. Cancer Stem Cells. Methods in Molecular Biology 2024; 2777: 19 doi: 10.1007/978-1-0716-3730-2_2
|
| 24 |
Maria Assunta Zocco, Anna Chiara Piscaglia, Felice Giuliante, Vincenzo Arena, Marialuisa Novi, Emanuele Rinninella, Annalisa Tortora, Carlo Rumi, Gennaro Nuzzo, Fabio Maria Vecchio, Giuseppe Bombardieri, Antonio Gasbarrini. CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease. Digestive and Liver Disease 2011; 43(2): 147 doi: 10.1016/j.dld.2010.06.008
|